Simon Farrell - Insider Non-Derivative Transactions at Trevi Therapeutics, Inc. (TRVI) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 20, 2023, Simon Farrell's relationship to Trevi Therapeutics, Inc. (TRVI) is Officer (Chief Commercial Officer), and currently has 45,650 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other TRVI insiders.
Data Source: SEC.
Simon Farrell - Insider Non-Derivative Transactions of TRVI Common Stock
Simon Farrell - Insider Non-Derivative Transactions at TRVI
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 21, 2023 | M -- (Common Stock) | 6250 | 0.51 | 45650 |
| Mar 8, 2023 | M -- (Common Stock) | 18750 | 0.51 | 39400 |